4//SEC Filing
CUMBERLAND PHARMACEUTICALS INC 4
Accession 0001209191-17-037364
$CPIXCIK 0001087294operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:21 PM ET
Size
4.4 KB
Accession
0001209191-17-037364
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Purchase
Common Stock
2017-05-31$6.95/sh+300$2,085→ 14,947 total
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeoperating
IncorporatedTN
Related Parties
1- filerCIK 0001087294
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:21 PM ET
- Size
- 4.4 KB